Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Trevena Inc (TRVN)  
$0.46 0.02 (3.45%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 7,710,000
Market Cap: 3.54(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5012 - $3.11
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV027, which is an angiotensin II type 1 receptor selective agonist, for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; and TRV045, which is a S1P modulator.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 31,785
Total Sell Value $0 $0 $0 $13,032
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 22
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bourdow Carrie L. President & CEO   •       •      –    2021-06-28 4 B $1.79 $100,542 D/D 56,200 1,301,510 2.81 -40%     
   Shin Barry Chief Financial Officer   •       –      –    2021-06-25 4 D $1.96 $48,285 D/D (24,635) 535,965     -
   Applebaum Scott CLCO; SVP, Regulatory Affairs   •       –      –    2021-02-10 4 D $2.85 $60,357 D/D (21,178) 344,022     -
   Applebaum Scott CLCO; SVP, Regulatory Affairs   •       –      –    2020-12-17 4 A $0.00 $0 D/D 115,200 365,200     -
   Shin Barry Chief Financial Officer   •       –      –    2020-12-17 4 A $0.00 $0 D/D 157,000 560,600     -
   Bourdow Carrie L. President & CEO   •       •      –    2020-12-17 4 A $0.00 $0 D/D 471,100 1,264,060     -
   Demitrack Mark Sr. VP & Chief Medical Officer   •       –      –    2020-12-17 4 A $0.00 $0 D/D 172,700 444,181     -
   Yoder Robert T SVP, Chief Commercial Officer   •       –      –    2020-12-17 4 A $0.00 $0 D/D 141,300 357,866     -
   Bourdow Carrie L. President & CEO   •       •      –    2020-12-07 4/A D $2.27 $344,323 D/D (151,684) 1,245,310     -
   Bourdow Carrie L. President & CEO   •       •      –    2020-12-07 4 D $2.27 $301,760 D/D (132,934) 792,960     -
   Yoder Robert T Sr VP Chief Commercial Officer   •       –      –    2020-12-07 4 D $2.27 $83,282 D/D (36,688) 216,566     -
   Demitrack Mark Sr. VP & Chief Medical Officer   •       –      –    2020-12-07 4 D $2.27 $110,224 D/D (48,557) 271,481     -
   Shin Barry Chief Financial Officer   •       –      –    2020-12-07 4 D $2.27 $95,024 D/D (41,861) 403,600     -
   Shin Barry Chief Financial Officer   •       –      –    2020-06-25 4 D $1.72 $40,487 D/D (23,539) 445,461     -
   Applebaum Scott CLCO; SVP Regulatory Affairs   •       –      –    2020-02-10 4 A $0.00 $0 D/D 250,000 250,000     -
   Demitrack Mark Sr. VP & Chief Medical Officer   •       –      –    2019-12-12 4 A $0.00 $0 D/D 213,000 320,038     -
   Shin Barry Chief Financial Officer   •       –      –    2019-12-12 4 A $0.00 $0 D/D 194,000 469,000     -
   Bourdow Carrie L. President and CEO   •       •      –    2019-12-12 4 A $0.00 $0 D/D 657,000 925,894     -
   Yoder Robert T Sr. VP, Chief Business Officer   •       –      –    2019-12-12 4 A $0.00 $0 D/D 167,000 253,254     -
   Yoder Robert T Sr. VP, Chief Business Officer   •       –      –    2019-12-02 4 D $0.69 $4,735 D/D (6,874) 86,254     -
   Bourdow Carrie L. President and CEO   •       •      –    2019-12-02 4 D $0.69 $12,265 D/D (17,804) 268,894     -
   Demitrack Mark Sr. VP & Chief Medical Officer   •       –      –    2019-12-02 4 D $0.69 $6,188 D/D (8,982) 107,038     -

  22 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed